Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
16.25
-0.93 (-5.41%)
At close: May 12, 2025, 4:00 PM
16.04
-0.21 (-1.29%)
After-hours: May 12, 2025, 7:53 PM EDT

Telix Pharmaceuticals Market Cap

Telix Pharmaceuticals has a market cap or net worth of $5.27 billion as of May 12, 2025. Its market cap has increased by 56.81% in one year.

Market Cap
5.27B
Enterprise Value
5.19B
1-Year Change
56.81%
Ranking
Category
Stock Price
16.25

Market Cap Chart

Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $5.27B, an increase of 4,473.31%. That is a compound annual growth rate of 66.56%.

History

DateMarket Cap% Change
May 12, 20255.31B4.11%
Dec 31, 20245.10B129.18%
Dec 29, 20232.22B42.30%
Dec 30, 20221.56B-2.70%
Dec 31, 20211.61B96.45%
Dec 31, 2020817.72M196.48%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 678.68B
Johnson & Johnson 372.12B
UnitedHealth Group 344.46B
AbbVie 338.48B
Novo Nordisk 292.03B
Abbott Laboratories 230.58B
Novartis AG 213.30B
AstraZeneca 210.42B
Market Cap Rankings